Total submissions: 19
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000244604 | SCV000302007 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000269609 | SCV000470591 | benign | Ehlers-danlos syndrome, arthrochalasia type, 2 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV000323983 | SCV000470592 | benign | Osteogenesis imperfecta | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Gene |
RCV000244604 | SCV000516229 | benign | not specified | 2016-03-03 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Laboratory for Molecular Medicine, |
RCV000244604 | SCV000538714 | benign | not specified | 2016-04-25 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF |
Athena Diagnostics Inc | RCV000244604 | SCV000612915 | benign | not specified | 2017-07-26 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000987925 | SCV001137419 | benign | Ehlers-Danlos syndrome, classic type | 2019-05-28 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001812668 | SCV001156702 | benign | not provided | 2023-11-30 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001512869 | SCV001720359 | benign | Osteogenesis imperfecta type I; Ehlers-Danlos syndrome, classic type, 1 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000269609 | SCV001821878 | benign | Ehlers-danlos syndrome, arthrochalasia type, 2 | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001589218 | SCV001821879 | benign | Osteogenesis imperfecta, recessive perinatal lethal | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001589216 | SCV001821880 | benign | Osteogenesis imperfecta type III | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001589217 | SCV001821881 | benign | Osteogenesis imperfecta with normal sclerae, dominant form | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000323983 | SCV002564776 | benign | Osteogenesis imperfecta | 2022-07-18 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002277599 | SCV002565563 | benign | Ehlers-Danlos syndrome | 2022-07-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002392755 | SCV002704014 | benign | Cardiovascular phenotype | 2018-12-04 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Diagnostic Laboratory, |
RCV000244604 | SCV001739729 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000244604 | SCV001808434 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000244604 | SCV001954506 | benign | not specified | no assertion criteria provided | clinical testing |